Skip to content

luciana pechmann

  • MD
  • Clinical Director Centro de Diabetes Curitiba
  • Centro de Diabetes Curitiba
  • 1h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 2CitationsNumber of citations received by luciana's publications. Updated daily.

Other IDs

Research interests

sarcopeniaosteoporosisdiabetes

Co-authors (8)

  • VICTORIA BORBA

Publications (2)

  • A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2

    • Vianna A
    • Lacerda C
    • Pechmann L
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: A randomized controlled trial NCT01679899 NCT

    • Vianna A
    • De Lacerda C
    • Pechmann L
    • et al.
    N/AReaders
    2Citations
    Get full text

Professional experience

Clinical Director Centro de Diabetes Curitiba

Centro de Diabetes Curitiba

January 2006 - Present